Conceptos actuales en enfermedad celíaca / Current concepts on celiac disease

No disponible

La importancia de la nutrición en los primeros 1.000 días / The importance of nutrition in the first 1000 days

No disponible

Increased resting energy expenditure by fat-free mass in children and teenagers with constitutional leanness.

BACKGROUND/OBJECTIVES: To compare the resting energy expenditure (REE) and the REE/Fat-free-mass (FFM) quotient in children with constitutional leanness (CL) and children with normal body weight, and to describe the within-family clustering of CL. SUBJECTS/METHODS: We have studied 18 children and teenagers with CL, 10 girls and 8 boys, and 18 gender and age matched normal controls, with the same pubertal stage. All were recruited from the outpatient pediatric clinic nutrition unit. None of the children with CL showed symptoms of chronic illness, they had normal laboratory results, they had a normal caloric food intake, and they did not agree with the DSM-IV-TR criteria for anorexia nervosa. We describe the body mass index (BMI) of children and their parents. The children were classified according to Cole's recently published BMI cut-offs for thinness: under 18.5 points in CL group, stable at least in the last year, and between 18.5 and 25 cutt-offs in the control group. The body composition was calculated by anthropometric methods (skinfold thickness measurements). In addition REE was measured using fasting indirect calorimetry. RESULTS: The CL group had a higher mean percentage of FFM, and a mean FM significantly less, relative to controls (p < 0.001). The average absolute REE was significantly lower in the CL group (1,106.55 ± 240.72 kcal) than the control group (1,353.33 ± 270.01 kcal/dia) (p < 0.01). However, the REE adjusted for FFM showed a mean significantly greater in the CL group (41.39 ± 2.26 kcal/kg FFM) (Mean confidence interval (CI) 95 %: 40.33-42.45) than the controls (37.37 ± 3.06 kcal/kg FFM) (Mean CI 95 %: 35.93-38.81) (p < 0.001). Finally, in the family study, the mean BMI of fathers of CL group was significantly lower (p < 0.01), but there were not any differences in the mean BMI of mothers. Among parents with BMI known, 8 of 35 parents of CL group had an BMI lower 18.5, and only 2 of 36 parents in the control group (p < 0.05). CONCLUSIONS: This increased energy expenditure-to-FFM ratio differentiates between CL and controls. These metabolic differences are probably genetically determined.

Increased resting energy expenditure by fat-free mass in children and teenagers with constitutional leanness / Incremento del gasto energético en reposo por masa libre de grasa en niños y adolescentes con delgadez constitucional

Background/objectives: To compare the resting energy expenditure (REE) and the REE/Fat-free-mass (FFM) quotient in children with constitutional leanness (CL) and children with normal body weight, and to describe the within-family clustering of CL. Subjects/methods: We have studied 18 children and teenagers with CL, 10 girls and 8 boys, and 18 gender and age matched normal controls, with the same pubertal stage. All were recruited from the outpatient pediatric clinic nutrition unit. None of the children with CL showed symptoms of chronic illness, they had normal laboratory results, they had a normal caloric food intake, and they did not agree with the DSM-IV-TR criteria for anorexia nervosa. We describe the body mass index (BMI) of children and their parents. The children were classified according to Cole's recently published BMI cut-offs for thinness: under 18.5 points in CL group, stable at least in the last year, and between 18.5 and 25 cutt-offs in the control group. The body composition was calculated by anthropometric methods (skinfold thickness measurements). In addition REE was measured using fasting indirect calorimetry. Results: The CL group had a higher mean percentage of FFM, and a mean FM significantly less, relative to controls (p < 0.001). The average absolute REE was significantly lower in the CL group (1,106.55 ± 240.72 kcal) than the control group (1,353.33 ± 270.01 kcal/dia) (p < 0.01). However, the REE adjusted for FFM showed a mean significantly greater in the CL group (41.39 ± 2.26 kcal/kg FFM) (Mean confidence interval (CI) 95 %: 40.33-42.45) than the controls (37.37 ± 3.06 kcal/kg FFM) (Mean CI 95 %: 35.93-38.81) (p < 0.001). Finally, in the family study, the mean BMI of fathers of CL group was significantly lower (p < 0.01), but there were not any differences in the mean BMI of mothers. Among parents with BMI known, 8 of 35 parents of CL group had an BMI lower 18.5, and only 2 of 36 parents in the control group (p < 0.05). Conclusions: This increased energy expenditure-to-FFM ratio differentiates between CL and controls. These metabolic differences are probably genetically determined (AU)

Objetivos: Comparar el gasto energético en reposo (GER) y el cociente GER/masa libre de grasa (MLG) entre niños con delgadez constitucional (CL) y niños con peso normal, y describir la agregación familiar de la DC. Material y métodos: Hemos estudiados 18 niños y adolescentes con DC, 10 niñas y 8 niños, y 18 controles pareados con aquellos por edad, sexo y mismo estadio puberal. Todos fueron captados en la consulta externa de la Unidad de Nutrición clinica infantil. Ninguno de los niños con DC mostraba sintomas de enfermedad crónica, todos presentaban hallazgos de laboratorio normales, tuvieron una ingesta calórica normal, y no cumplieron en ningún caso criterios de anorexia nerviosa según la DSM-IV-TR. Se describe el indice de masa corporal (IMC) de los niños y de sus padres. Los niños fueron clasificados según los puntos de corte de IMC para definición de delgadez recientemente publicados por Cole: inferior al punto 18.5 en el grupo de DC, estable durante al menos un año, y entre los puntos de corte 18.5 y 25 en el grupo control. La composición corporal fue calculada por métodos antropométricos (medida de pliegues cutáneos). Además, el GER fue determinado mediante calorimetria indirecta en ayunas. Resultados: El grupo de DC tuvo un porcentaje de MLG medio mayor, y una masa grasa (MG) media significativamente menor, en relación con los controles (p < 0,001). El GER absoluto medio fue significativamente más bajo en el grupo con DC (1.106,5 ± 240,72 kcal) que en el grupo control (1.353,3 ± 270,01 kcal/dia) (p < 0,01). Sin embargo, el GER ajustado por MLG mostró una media significativamente mayor en el grupo de DC (41,39 ± 2,26 kcal/kg MLG) (Intervalo de confianza (IC) de la media al 95%: 40,33-42,45) que en los controles (37,37 ± 3.06 kcal/kg MLG) (CI 95%: 35,93-38,81) (p < 0,001). Finalmente, en el estudio familiar, el IMC medio de los padres del grupo con DC fue significativamente más bajo (p < 0,01), pero no hubo ninguna diferencia entre el IMC de las madres. Entre los padres con IMC conocido, 8/35 padres del grupo con DC presentaron un IMC menor de 18,5, por sólo 2/36 padres del grupo control (p < 0.05). Conclusiones: El incremento en el GER por MLG diferencia niños con DC de controles. Estas diferencias metabólicas podrían estar determinadas genéticamente (AU)

La prevención y el tratamiento del cólico del lactante / Prevention and treatment for infant colic

No disponible

Los alimentos funcionales a la luz de la normativa europea / Functional foods in light of the European regulation

No disponible

Giardiasis resistente a metronidazol: a propósito de un caso / No disponible

Giardia lamblia es uno de los parásitos intestinales patógenos más frecuente, causante de enfermedad tanto autóctona como importada. Aunque la infección es asintomática en la mayoría de los casos, puede cursar con patología digestiva diversa. Los derivados nitroimidazólicos, en especial el metronidazol, continúan siendo el tratamiento de elección. El aumento en el número de resistencias ha hecho necesario la introducción de nuevas pautas terapéuticas. Se presenta un caso de giardiasis resistente a metronidazol, que respondió a tratamiento con quinacrina

Giardia Lamblia is one of the most frequent intestinal pathogen parasite, responsible for autochthonous as well as imported illness. Although the infection is asymptomatic in the majority of the cases, it can be revealed by several digestive conditions. Nitroimidazole derivatives, especially Metronidazole, keep on being the treatment of choice. The increase in the number of resistances has made necessary the introduction of new therapeutical patterns. A case of giardiasis resistant to metronidazole which responded to a quinacrine treatment is presented

[The tumor necrosis factor system and leptin in coeliac disease]. / Sistema factor de necrosis tumoral y leptina en la enfermedad celíaca.

OBJECTIVE: Patients with coeliac disease (CD) present anorexia and malnutrition. Leptin is a significant anorexigenic factor, with a close relationship to the body mass index. The aims of this study were to asses serum leptin levels in CD and their possible influence on appetite, as well as to compare and relate leptin with tumor necrosis factor (TNF) activity, which has similar functions. METHODS: Leptin and TNF receptor-1 (TNFr-1) were measured by enzyme-linked immunosorbent assay. Sixty-five serum samples from patients with CD (28 boys and 37 girls) were analyzed. In all patients, small bowel biopsy and anti-endomysium determination were performed simultaneously. Twenty-nine patients presented active CD and 36 were in remission. RESULTS: Leptin concentrations were reduced in active CD (p = 0.002). In patients in remission, leptin was related to the body mass index (p = 0.001), but this correlation was not found during the active phase of the disease. Contrary to normal differences between sexes, in active CD leptin levels were similar in boys and girls. TNFr-1 was found in all serum samples and levels were statistically higher in patients with active CD (p = 0.0003), suggesting that the TNF system is activated in this disease. CONCLUSIONS: Leptin concentrations were reduced in active CD, but we did not find the usual positive correlation with body mass index and higher concentrations in girls. These results suggest that leptin does not contribute to anorexia and failure to thrive in patients with CD; in contrast, the TNF system might be involved.

Sistema factor de necrosis tumoral y leptina en la enfermedad celíaca / The tumor necrosis factor system and leptin in coeliac disease

Objetivo: Los enfermos celíacos presentan malnutrición y una gran anorexia. La leptina es un importante factor anorexígeno estrechamente relacionado con el índice de masa corporal (IMC). El objetivo fue estudiar la leptina sérica en la enfermedad celíaca y su posible acción sobre el apetito, compararla y relacionarla con el factor de necrosis tumoral (TNF), que tiene funciones similares. Métodos: La leptina y el receptor I de TNF (TNF-R-I) se midieron mediante enzimoinmunoanálisis (ELISA). Se analizaron 65 sueros de enfermos celíacos (28 varones y 37 mujeres). En todos los casos se practicó simultáneamente biopsia intestinal y se determinaron anticuerpos antiendomisio. Estaban en actividad 29 casos y 36 en remisión. Resultados: Los valores de leptina estaban disminuidos en la fase de actividad de la enfermedad celíaca (p 0,002), lo que no apoya su participación sobre la anorexia y la desnutrición del paciente celíaco. Durante la remisión de la enfermedad celíaca la leptina se relaciona con el IMC (p 0,001), pero en la fase activa se rompe esta relación habitual. En la fase aguda también se rompe la diferencia entre sexos, y son similares los valores en varones y mujeres. El TNF-R-I se detectó en todos los sueros y mostró una elevación significativa durante la fase aguda (p 0,0003) lo que parece indicar una activación del sistema TNF en la enfermedad celíaca. Conclusiones: La leptina está disminuida durante la fase activa de la enfermedad, y se pierde su habitual correlación con el IMC y el sexo femenino. Los resultados señalan que no participa en la anorexia y la desnutrición de la enfermedad celíaca y, sin embargo, sí podría hacerlo el sistema TNF (AU)

Alimentación del preescolar, escolar y adolescente. Situaciones especiales: dietas vegetarianas y deporte / Diets in pre-school, school and adolescent age groups. Special situations: vegetarian diets and physical exercise

Unas correctas normas nutricionales entre el año y los 18 años de edad son fundamentales, no sólo para el crecimiento, la maduración y el óptimo estado de salud, sino para el establecimiento de los futuros hábitos dietéticos. El conocimiento de unas buenas normas dietéticas en el niño, en el seno familiar y en los educadores debe ser una práctica que los pediatras debemos fomentar, ya que desde la infancia errores en la alimentación pueden tener implicaciones en la etapa adulta, como comentaremos a lo largo del texto (AU)

Valor de los marcadores serológicos en el diagnóstico de la enfermedad celíaca. Propuesta de un protocolo / Value of serological markers in the diagnosis of celiac disease. A proposed guidelinebackground

OBJETIVO: La alta frecuencia de casos atípicos de enfermedad celíaca y de formas con pobre sintomatología ha potenciado la búsqueda de marcadores analíticos que apoyen la indicación de la biopsia intestinal. Las pruebas más extendidas son la determinación de anticuerpos antigliadina de clase IgG e IgA (AAGIgG y AAGIgA) y antiendomisio (AEmIgA). MÉTODOS: Se presenta la experiencia de 10 años, estudiando AAG en 1.075 sueros de pacientes con enfermedad celíaca y AEmIgA en 534. Los marcadores séricos se compararon a la biopsia intestinal en 152 casos en los que se realizaron simultáneamente. RESULTADOS: En los casos con atrofia intestinal grave fue la alta sensibilidad de los AAGIgG (91 por ciento) y de los AEmIgA (94 por ciento), quienes además mostraron el valor predictivo positivo (88 por ciento) y negativo (97 por ciento) más altos. Un título positivo de AEmIgA coincidió con una biopsia alterada al 100 por ciento de los casos. Los AEmIgA fueron también el marcador más eficaz para el control de la dieta sin gluten. Sin embargo, en los casos con atrofia parcial de la mucosa intestinal ningún marcador fue lo bastante indicativo. CONCLUSIÓN: Los AEmIgA son el mejor marcador serológico de enfermedad celíaca. A la luz de los resultados y según la prevalencia estimada de esta enfermedad, se proponen protocolos de utilización de los marcadores serológicos para el diagnóstico de los síndromes malabsortivos, para estudios de poblaciones de bajo y alto riesgo de enfermedad celíaca y para el seguimiento de los pacientes diagnosticados (AU)

Consenso de actuación ante determinadas patologías del aparato digestivo en fibrosis quística. Tratamiento de la insuficiencia pancreática exocrina y síndrome de obstrucción del intestino distal / Cystyc fibrosis: treatment of pancreatic insufficiency and distal intestinal obstruction syndrome

No disponible

[Value of serological markers in the diagnosis of celiac disease. A proposed protocol]. / Valor de los marcadores serológicos en el diagnóstico de la enfermedad celíaca. Propuesta de un protocolo.

AIM: In recent years, the high frequency of atypical cases of celiac disease (CD) and of forms of this disease with minor symptoms has prompted the search for analytical markers that may support indications for intestinal biopsy. The commonest tests are those for serum class IgG and IgA antigliadin antibodies (IgG-AGA, IgA-AGA) and IgA antiendomysial antibodies (IgA-EmA). METHODS: We report our 10 year experience of studying AGA in 1,075 serum samples from patients with CD and IgA-EmA in 534 samples. The serological markers were compared with 152 intestinal biopsies performed simultaneously with the other tests. RESULTS: In patients with severe intestinal atrophy the sensitivity of IgA-AGA (91%) and IgA-EmA (94%) was high. IgA-EmA and the latter showed the highest positive (88%) and negative (97%) predictive values. In all patients, IgA-EmA positivity coincided with alterations in the biopsy. Determination of IgA-EmA was also the most efficient marker for monitoring the gluten free diet phase. However, in patients in whom minimal histological changes were found in the intestinal mucosa, none of the markers was sufficiently accurate. RESULTS: IgA- EmA antibodies are the most accurate serological marker of CD. In view of these results and the estimated prevalence of the disease, protocols for the use of serological markers are proposed for the differential diagnosis of malabsorption symptoms, for use in patients at low and high risk of CD and for the followup of those with a diagnosis of CD.

[Resting energy expenditure in cystic fibrosis]. / Gasto energético en reposo en fibrosis quística.

OBJECTIVE: Study of Resting Energy Expenditure (REE) by indirect calorimetry in patients with Cystic Fibrosis (CF), with the aim of determine its possible increase and its relationship with nutritional clinic and analitic parameters. PATIENTS AND METHODS: Measurement of REE in 18 patients (11 female) with CF, without acute pulmonary exacerbation. Their age was between 5 years 3 months and 21 years 7 months. REE was expressed as kcal/day and as percentage of the predictive education of World Health Organization (WHO) for calculation of REE in function of gender, age and weight. It was also determined complete anthropometry and body composition derived (Siri), bioelectrical impedance, pulmonary function (FEV1 and FVC), chest X-ray (Score Chrispin) and blood sample (leucocits, VSG, IgM, vitamin A, C, E and serum lipids). RESULTS: The mean REE was 1280 +/- 246 kcal/day. There was strong correlation with fat free mass (anthropometry) (r: 0.92; p < 0.0001) and with ratio height 2/resistance by bioelectric impedance (r: 0.89; p < 0.0001). If expressed as percentage of WHO education, REE was 104.2 +/- 9.8%. In chronic infected by Pseudomona sp. was 106.8 +/- 11.5% and 101.0 +/- 6.6 in no infected patients. REE was 102.9 +/- 6.4% in prepubertal subjects, 102.2 +/- 10.8% in pubertal, and 108.6 +/- 12.1 in postpubertal subjects. There was no significative correlation with nutritional status, but it was reported significative correlation with severity of pulmonary disease (FEV1: r: -0.58; p < 0.05. Score Chrispin: r: 0.62; p < 0.005). There was also significative correlation with ratio vitamin E/cholesterol (r: -0.60; p < 0.05), but not with another analitic parameters. CONCLUSIONS: REE is strong correlated with fat free mass in patients with CF. The increased REE values over normal ones is related with severity of pulmonary disease. The decrease of ratio Vitamin E/cholesterol is also related with increase of REE.

[Increased serum levels of soluble IL-2 receptor in food intolerance: possible mechanism of delayed immunity in milk intolerance]. / Aumento sérico del receptor soluble de IL-2 en la intolerancia alimentaria: posible mecanismo de inmunidad retardada en la alergia a la leche de vaca.

The levels of soluble interleukin-2 receptor (sIL-2R) were measured in 35 serum samples from children with food intolerance; 19 had an IgE-mediated sensitization and were considered as atopic patients, skin tests and RAST were negative in the remaining 16 children and they were diagnosed as having cow milk intolerance (CMI) Forty-three coeliac patients were included as a positive control group and 18 normal children as the negative control group. The atopic group showed normal values of sIL-2R (1,183 +/- 468 u/ml); however, it was increased in children with CMI (1,453 +/- 469 u/ml, p < 0.05). The sIL-2R mean value was highest in patients with gastrointestinal symptoms (1,458 +/- 461 u/ml, p: 0.03) and the presence of atopic dermatitis was not relevant. The sIL-2R was also elevated in 8 children with igE-mediated sensitization against cow's milk (1,477 +/- 328 u/ml, p < 0.05). These results suggest that a delayed cellular mechanism occurred in CMI, similar to that present in coeliac disease, although it was less severe. In addition, there is an overlap of humoral and cellular immunological mechanisms in the IgE-mediated sensitization to cow's milk, but we did not find this coincidence in the allergy to remaining foods. From a pathogenic point of view, to separate CMI from IgE-mediated allergies to milk does not seem to be sufficiently justified at the present time. It is possible that the atopy against cow milk proteins in children has a different immunological mechanism than the atopy to other foods, which would explain its better prognosis.

[Secondary carbohydrate intolerance. Evolutive follow-up (author's transl)]. / Intolerancia secundaria a hidratos de carbono. Control evolutivo.

This study reports 70 children suffering from malabsorption and/or carbohydrate intolerance followed for at least twelve months. Mono and dysaccharide overload curves are considered as very valuable tests together with the clinical signs. These must be carefully observed during the tests and after supression of the malabsorbed sugar. Reliability of the overload tests in the follow-up is pointed out. Variations in the normalization time of the curves for each carbohydrate are determined. Finally 90 min. is considered as an advisable end-point for overload tests.